Please Wait a Moment
X

Articles

02Jan

IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization

02 Jan, 2024 | Return|

VP of Scientific Affairs Marion Lanteri recently joined the International Plasma and Fractionation Association (IPFA) executive board, as CTS joined as a member. She said of her appointment, “It is my honor to represent CTS internationally and to create new opportunities. I am also grateful that CTS invested in this membership, and I will make the best of it.” 

Marion_Lanteri_emailIPFA’s mission is to support and promote the activities of nonprofit organizations around the globe engaged in the collection and fractionation of plasma to enable robust, safe supply and patient access to plasma-derived medicines. Additionally, through education and collaboration with stakeholders, they advocate for public health values and donor health protection.

According to an IPFA article, CTS’s membership brings a new category of contribution to IPFA from nonprofit research and clinical testing institutions. They describe this sector as being at the heart of the association and bringing together the different stakeholders that CTS represents and works with.

President & CEO Sally Caglioti said of the news, “I’m grateful to Marion for representing us with IPFA. Professional networking is a big part of why we have had so many growth opportunities at CTS. Building relationships and trust with external colleagues opens up all kinds of doors.”

Related

Reminder-MD Revised Headers on CTS forms

Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...

Read More >

CTS Form Updates 2020

CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...

Read More >

Reminder-Bio-Rad Geenius HIV 1/2 Implemented

CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...

Read More >

Update on the Ortho Conversion

At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...

Read More >

MD Revised Headers on CTS forms

Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...

Read More >

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >